Option chain shows key data for Salarius Pharmaceuticals's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Salarius Pharmaceuticals.

Salarius Pharmaceuticals (NASDAQ:SLRX) Stock, Option Chain

Salarius Pharmaceuticals

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

benzinga_deal_dispatch2

News

ABBV

BIIB

LNTH

NGVT

NPSCY

RVNC

SAGE

SANW

SLRX

TMUS

Deal opportunities abound: KKR &amp; Co.&#39;s stake in Maya; DuPont&#39;s electronics business; Ingevity&#39;s North Charleston site; and S&amp;W Seed Company.

Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt

Genetic,Research,And,Biotech,Science,Concept.,Human,Biology,And,Pharmaceutical

Movers

Salarius Pharmaceuticals (NASDAQ: SLRX) shares are trading higher Monday after the company announced a merger agreement with Decoy Therapeutics, a privately held biopharmaceutical company. 

Salarius Pharmaceuticals Shares Are Skyrocketing Today: What&#39;s Going On?

SPDR Gold Shares (GLD)

Earnings

Equities

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

CMTL

ITCI

MRNA

PHIO

Gold Down Over 1%; Salarius Pharmaceuticals Shares Surge

Salarius Pharmaceuticals, Inc. - Common Stock

Salarius Pharmaceuticals Inc

Warning: SLRX is at high risk of performing badly

Salarius Pharmaceuticals ( ($SLRX) ) has issued an announcement. Salarius Pharmaceuticals has entered into a merger agreement with Decoy Therapeuti...

Salarius Pharmaceuticals Merges with Decoy Therapeutics

Salarius Pharmaceuticals and Decoy Therapeutics announce merger

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include:&nbsp...

Biotech Alert: Searches spiking for these stocks today

ARDX

AZTR

BDTX

CGEN

CLRB

ERNA

GTBP

IBIO

KAPA

SLXN

SNGX

Press Releases

Salarius Provides Update on Strategic Review Process and Plans to Support Ongoing Seclidemstat Clinical Trials by Further Reducing Expenses

Salarius Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Salarius Pharmaceuticals Announces 1-for-8 Reverse Stock Split

Clinical Data on Salarius Pharmaceuticals' Seclidemstat in Patients with MDS and CMML Presented at the 2024 European Hematology Association Annual Meeting

Salarius Pharmaceuticals and Decoy Therapeutics Announce Definitive Merger Agreement

Shareholder Alert: Ademi LLP investigates whether Salarius Pharmaceuticals, Inc. is obtaining a Fair Price for its Public Shareholders

Allarity Therapeutics, Inc. - Common stock

Allarity Therapeutics

AquaBounty Technologies, Inc. - Common Stock

AquaBounty Techs

180 Life Sciences

Anitra

Bio-Path Hldgs

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

Pasithea Therapeutics Corp. - Common Stock

Pasithea Therapeutics

Lipella Pharmaceuticals Inc. - Common Stock

Lipella Pharmaceuticals

Matinas Biopharma Holdings, Inc. Common Stock

Matinas BioPharma Hldgs

Oragenics

Onconetix

Palisade Bio

Portage Biotech

Protagenic Therapeutics, Inc. - Common Stock

Protagenic Therapeutics

Qualigen Therapeutics, Inc. - Common Stock

Qualigen Therapeutics

Quoin Pharmaceuticals, Ltd. - American Depositary Shares

Quoin Pharmaceuticals

Revelation Biosciences, Inc. - Common Stock

Revelation Biosciences

Scinai Immunotherapeutics Ltd. - American Depositary Shares

Scinai Immunotherapeutics

Shuttle Pharmaceuticals Holdings, Inc. - common stock

Shuttle Pharmaceuticals

Synaptogenix

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics

TC BioPharm (Holdings) plc - American Depositary Shares

TC BioPharm (Holdings)

Tharimmune

Theriva Biologics

ZyVersa Therapeutics, Inc. - Common Stock

Comments

Salarius Pharmaceuticals

Salarius Pharmaceuticals (SLRX) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga